What were Global Health Ltd's latest quarterly results?
Global Health Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: +40.6% (stable)
- Revenue Growth YoY: +24.5%
- Operating Margin: 21.0% (volatile)
Global Health Ltd: Why Is It Outperforming Nifty 500?
ActiveRS +22.2%Average6w Streak
In , Global Health Ltd (Hospitals) is outperforming Nifty 500 with +22.2% relative strength. Fundamentals: Average. On a 6-week streak.
Global Health Ltd Key Facts
- PE Ratio
- 63.3x
- Market Cap
- ₹35,287 Cr
- PAT Growth YoY
- +41%
- Revenue Growth YoY
- +25%
- OPM
- 21.0%
- RS vs Nifty 500
- +22.2%
Emerging Opportunity
What's Happening
⏳Steady earner with flat PE — waiting for re-rate catalyst
💪Debt reduced 21% YoY — balance sheet strengthening
🌐FII stake decreased 0.8% this quarter
🏛️DII accumulation — stake up 1.9%
💰Trading 50% above estimated fair value — significant premium
Key Numbers
PAT Growth YoY
+41%
Stable
Revenue YoY
+25%
Stable
Operating Margin
21.0%
-300 bps YoY
PE Ratio
63.3
Current Price
₹1,312
Dividend Yield
0.04%
Fundamental Score
47/100
Average
3Y PAT CAGR
+19%
Market Cap
35.3K Cr
Valuation
Significantly Overvalued12-Week Performance
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
12 weeks agoThis week
How Fast Is Global Health Ltd Growing?
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +25% | +18% | Stable |
| PAT (Net Profit) | +41% | +19% | Stable |
| OPM | 21.0% | -300 bps | Volatile |
Other Top Hospitals Stocks Beating Nifty 500
Frequently Asked Questions: Global Health Ltd
Based on publicly available financial data. This is educational research, not investment advice.
Is Global Health Ltd's profit growing or declining?
Global Health Ltd's profit is growing with an stable trend.
- PAT Growth YoY: +40.6% (latest quarter)
- PAT Growth QoQ: +49.5% (sequential)
- 3-Year PAT CAGR: +19.3%
- Trend: Stable — consistent growth pattern
What is Global Health Ltd's revenue growth trend?
Global Health Ltd's revenue growth trend is stable.
- Revenue Growth YoY: +24.5%
- Revenue Growth QoQ: +3.4% (sequential)
- 3-Year Revenue CAGR: +17.6%
How is Global Health Ltd's operating margin trending?
Global Health Ltd's operating margin is volatile.
- Current OPM: 21.0%
- OPM Change YoY: -3.0% basis points
- OPM Change QoQ: +2.0% basis points
What is Global Health Ltd's 3-year profit and revenue CAGR?
Global Health Ltd's long-term compounding rates
- 3-Year Profit CAGR: +19.3%
- 3-Year Revenue CAGR: +17.6%
Is Global Health Ltd's growth accelerating or decelerating?
Global Health Ltd's earnings growth is stable with mixed signals on a sequential basis.
- YoY Acceleration: +74.2% bps
- Sequential Acceleration: +89.4% bps
- Margin Warning: Operating margins are under pressure
What is Global Health Ltd's trailing twelve month (TTM) performance?
Global Health Ltd's trailing twelve month (TTM) performance
- TTM PAT: ₹554 Cr
- TTM PAT Growth: +15.2% YoY
- TTM Revenue: ₹4,000 Cr
- TTM Revenue Growth: +19.4% YoY
- TTM Operating Margin: 21.2%
Is Global Health Ltd overvalued or undervalued?
Global Health Ltd appears significantly overvalued based on our fair value analysis.
- Valuation Signal: Significantly Overvalued
- Current PE: 63.3x
- Price-to-Book: 8.9x
What is Global Health Ltd's current PE ratio?
Global Health Ltd's current PE ratio is 63.3x.
- Current PE: 63.3x
- Market Cap: 35.3K Cr
- Dividend Yield: 0.04%
How does Global Health Ltd's valuation compare to its history?
Global Health Ltd's current PE is 63.3x.
- Current PE: 63.3x
- Valuation Assessment: Significantly Overvalued
What is Global Health Ltd's price-to-book ratio?
Global Health Ltd's price-to-book ratio is 8.9x.
- Price-to-Book (P/B): 8.9x
- Book Value per Share: ₹147
- Current Price: ₹1312
Is Global Health Ltd a fundamentally strong company?
Global Health Ltd is rated Average with a fundamental score of 47.39/100. This score is calculated from objective financial metrics
- Revenue Growth YoY: +24.5% (10% weight)
- PAT Growth YoY: +40.6% (10% weight)
- PAT Growth QoQ: +49.5% (10% weight)
- Margins stable (10% weight)
Is Global Health Ltd debt free?
Global Health Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹1,000 Cr
What is Global Health Ltd's return on equity (ROE) and ROCE?
Global Health Ltd's return ratios over recent years
- FY2024: ROCE 20.0%
- FY2025: ROCE 20.0%
- FY2026: ROCE 17.0%
Is Global Health Ltd's cash flow positive?
Global Health Ltd's operating cash flow is positive (FY2026).
- Cash from Operations (CFO): ₹714 Cr
- Free Cash Flow (FCF): ₹-375 Cr
- CFO/PAT Ratio: 129% (strong cash conversion)
What is Global Health Ltd's dividend yield?
Global Health Ltd's current dividend yield is 0.04%.
- Dividend Yield: 0.04%
- Current Price: ₹1312
Who holds Global Health Ltd shares — promoters, FII, DII?
Global Health Ltd's shareholding pattern (Mar 2026)
- Promoters: 33.0%
- FII (Foreign): 10.2%
- DII (Domestic): 14.8%
- Public: 42.0%
Is promoter holding increasing or decreasing in Global Health Ltd?
Global Health Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 33.0% (Mar 2026)
- Previous Quarter: 33.0% (Dec 2025)
- Change: 0.00% (stable)
How long has Global Health Ltd been outperforming Nifty 500?
Global Health Ltd has been outperforming Nifty 500 for 6 consecutive weeks, indicating building momentum.
Is Global Health Ltd a new momentum entry or an established outperformer?
Global Health Ltd is an established outperformer with 6 weeks of consecutive Nifty 500 outperformance.
Is Global Health Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Global Health Ltd may be worth studying
- Earnings growing at +40.6% YoY
- Cash flow is positive — CFO ₹714 Cr
What is the investment thesis for Global Health Ltd?
Global Health Ltd investment thesis summary:
Research Signals (Bull Case)
- Revenue growing at +24.5% YoY
Risk Factors (Bear Case)
- Margins under pressure
- Appears significantly overvalued
What is the future outlook for Global Health Ltd?
Global Health Ltd's forward outlook based on current data signals
- Earnings Trend: stable
- Revenue Trend: stable
- Margin Trend: volatile
- Valuation: Significantly Overvalued
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.